Study Using WST11 in Patients With Localized Prostate Cancer

NCT00975429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: WST11
DRUG: WST11

Sponsor

Steba Biotech S.A.